blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1353670

EP1353670 - USE OF CHROMANES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  28.01.2005
Database last updated on 03.08.2024
Most recent event   Tooltip28.01.2005Application deemed to be withdrawnpublished on 16.03.2005  [2005/11]
Applicant(s)For all designated states
Bayer HealthCare AG
51368 Leverkusen / DE
[2004/01]
Former [2003/43]For all designated states
Bayer Aktiengesellschaft
51368 Leverkusen / DE
Inventor(s)01 / FAHRIG, Thomas
Im Luchsfeld 15
51429 Bergisch Gladbach / DE
02 / GERLACH, Irene
Kronenburger Str. 15
50935 Köln / DE
03 / HORVATH, Ervin
Theodor-Storm-Str. 4
51373 Leverkusen / DE
04 / JORK, Reinhard
Bachstr. 2c
42781 Haan / DE
05 / MAULER, Frank
Stargarder Str. 8
51491 Overath / DE
 [2003/43]
Application number, filing date02729419.803.01.2002
[2003/43]
WO2002EP00007
Priority number, dateDE200110191716.01.2001         Original published format: DE 10101917
[2003/43]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report
No.:WO02055078
Date:18.07.2002
Language:DE
[2002/29]
Type: A2 Application without search report 
No.:EP1353670
Date:22.10.2003
Language:DE
The application published by WIPO in one of the EPO official languages on 18.07.2002 takes the place of the publication of the European patent application.
[2003/43]
Search report(s)International search report - published on:EP13.03.2003
ClassificationIPC:A61K31/428, A61P25/16
[2003/43]
CPC:
A61K31/428 (EP,US); A61K31/425 (KR); A61P25/16 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/43]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:VERWENDUNG VON CHROMANEN[2003/43]
English:USE OF CHROMANES[2003/43]
French:UTILISATION DE CHROMANES[2003/43]
Entry into regional phase18.08.2003National basic fee paid 
15.09.2003Designation fee(s) paid 
15.09.2003Examination fee paid 
Examination procedure23.07.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
15.09.2003Examination requested  [2003/46]
21.04.2004Despatch of a communication from the examining division (Time limit: M04)
02.09.2004Application deemed to be withdrawn, date of legal effect  [2005/11]
07.10.2004Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2005/11]
Fees paidRenewal fee
02.02.2004Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]EP0749970  (BAYER AG [DE]) [X] 3,4 * claim 4 * * examples 2,3 * * paragraph [0042] - paragraph [0046] * * paragraph [0080] - paragraph [0081] *;
 [XD]WO9926621  (BAYER AG [DE], et al) [XD] 1-4 * claims 1,8 * * page 1; claim 6 *;
 [X]WO9929346  (BAYER AG [DE], et al) [X] 3,4 * claims 1-3,5,6 * * page 10, line 26 - page 11, line 7 *;
 [X]  - KLINE, A. E. ET AL, "The selective 5-HT1A receptor agonist repinotan HCl attenuates histopathology and spatial learning deficits following traumatic brain injury in rats", NEUROSCIENCE (OXFORD, UNITED KINGDOM) (2001), 106(3), 547-555, XP001128107 [X] 2,4 * page 550, column 1, paragraph 3 *

DOI:   http://dx.doi.org/10.1016/S0306-4522(01)00300-1
 [A]  - SEMKOVA, IRINA ET AL, "Neuroprotective effect of 5-HT1A receptor agonist, Bay.times.3702, demonstrated in vitro and in vivo", EUROPEAN JOURNAL OF PHARMACOLOGY (1998), 359(2/3), 251-260, XP001128106

DOI:   http://dx.doi.org/10.1016/S0014-2999(98)00634-7
 [A]  - KUKLEY, M. ET AL, "Effect of 5-hydroxytryptamine 1A receptor agonist BAY X 3702 on BCL-2 and BAX proteins level in the ipsilateral cerebral cortex of rats after transient focal ischaemia", NEUROSCIENCE (OXFORD, UNITED KINGDOM) (2001), 107(3), 405-413, XP001128108

DOI:   http://dx.doi.org/10.1016/S0306-4522(01)00369-4
 [A]  - VARIOUS, merck manual, N.J., MERVK RESEARCH LAB., (1999), XP002221547 [A] 1-4 * page 1466, column 2, paragraph 2 - paragraph 3 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.